Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02521857 · ClinicalTrials.gov registry record · Phase 1
A Water Consumption Study of ALKS 5461 in Healthy Volunteers
A Phase 1 study, sponsored by Alkermes.
- Completed
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
NCT02521857 is a Phase 1 study that has completed, run by Alkermes. The registered enrollment target is 30 participants.
The verdict
NCT02521857, a Phase 1 study, has completed, sponsored by Alkermes.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study will evaluate the impact of water consumption on the pharmacokinetics of ALKS 5461.
Interventions
- DRUG ALKS 5461
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-07 |
| Est. Completion | 2015-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02521857
The ClinicalTrials.gov registry entry for NCT02521857 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alkermes, which has 66 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ALKS 5461 is the first listed.
NCT02521857 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02521857 about?
NCT02521857 is a clinical study titled "A Water Consumption Study of ALKS 5461 in Healthy Volunteers". This study will evaluate the impact of water consumption on the pharmacokinetics of ALKS 5461.
What is the current status of trial NCT02521857?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2015-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT02521857?
The interventions under investigation include: ALKS 5461 (DRUG).
Who is sponsoring clinical trial NCT02521857?
This trial is sponsored by Alkermes, which has 66 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.